VIDEO: William F. Young, Jr., MD, Discusses JCEM Case Reports at ENDO 2022

William F. Young, Jr., MD, discusses the Endocrine Society’s newest journal, JCEM Case Reports, with Endocrine News editor Mark A. Newman. [VIDEO]

Endocrine News editor Mark A. Newman (left) discusses the Endocrine Society’s newest journal, JCEM Case Reports, with inaugural editor-in-chief William F. Young, Jr., at ENDO 2022 in Atlanta.

Among the throngs of attendees in the ENDO Expo hall at ENDO 2022 in Atlanta, newly named editor-in-chief of the Endocrine Society’s upcoming launch of JCEM Case Reports took time out of his busy schedule to chat with Endocrine News editor Mark A. Newman.

Young discusses why now is the right time for the Endocrine Society to publish a journal that delves into a number of case reports that will be a valuable educational tool for those clinicians who might come across a similar case in their own practice on occasion.

“We’re going to celebrate what we see every day in the clinic with challenging, interesting cases,” Young tells Newman, before detailing one of the earliest cases that confounded him as an internal medicine resident in 1979. “I was already enthralled with endocrine cases and the puzzles and challenges they represented and this kind of put a stamp on it.”

That early mystery that so baffled Young as an internist was then written up by him and his colleagues in the Journal of the American Medical Association. “That was my first clinical publication, and it really ignited my interest in clinical endocrinology,” he says, adding that from that first publication in 1979 to becoming the new editor-in-chief of JCEM Case Reports in 2022 “bookends my career.”

To get the details of Young’s early clinical dilemma and to hear more about JCEM Case Reports, click here.

To read Young’s interview with Endocrine News from the May issue, click here.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in